Liu J, Tsai Y L, Katz E, Compton G, Garcia J E, Baramki T A
The GBMC Fertility Centre, Greater Baltimore Medical Centre, Maryland 21204, USA.
Hum Reprod. 1997 Aug;12(8):1667-72. doi: 10.1093/humrep/12.8.1667.
The effect of in-vitro culture on the motility and morphology of fresh and frozen-thawed human testicular spermatozoa obtained from obstructive azoospermic patients and on the motility of testicular spermatozoa obtained from non-obstructive azoospermic patients was evaluated. The outcome of intracytoplasmic sperm injection (ICSI) with fresh and frozen-thawed human testicular spermatozoa was studied. The results showed that significant improvement of sperm morphology and motility was observed in culture of fresh (n = 17) and frozen-thawed (n = 15) testicular sperm samples obtained from patients with obstructive azoospermia. The motility of cultured testicular spermatozoa reached a peak at 72 h without the need for special media. In six of 20 samples obtained from patients with non-obstructive azoospermia, improvement of sperm motility was observed. When only non-motile testicular spermatozoa were cultured, they all remained non-motile (n = 9). In patients with obstructive azoospermia, fertilization rates of 80 and 81% were obtained using ICSI with fresh and frozen-thawed testicular spermatozoa respectively. Clinical pregnancies were observed in four out of nine patients with fresh testicular spermatozoa and two out of five patients after using frozen-thawed spermatozoa. When fresh testicular spermatozoa obtained from patients with non-obstructive azoospermia were used for ICSI, the fertilization rate was 68% and two out of seven patients achieved clinical pregnancies. In conclusion, the morphology and motility of fresh and frozen-thawed testicular spermatozoa in patients with obstructive azoospermia can be significantly improved after in-vitro culture. The outcome of in-vitro culture of testicular spermatozoa in patients with non-obstructive azoospermia is unpredictable. In-vitro culture of non-motile testicular spermatozoa is not successful so far. The outcome of ICSI with fresh and with frozen-thawed testicular spermatozoa was similar.
评估了体外培养对从梗阻性无精子症患者获取的新鲜及冻融后人睾丸精子活力和形态的影响,以及对从非梗阻性无精子症患者获取的睾丸精子活力的影响。研究了使用新鲜及冻融后人睾丸精子进行卵胞浆内单精子注射(ICSI)的结果。结果显示,从梗阻性无精子症患者获取的新鲜(n = 17)及冻融(n = 15)睾丸精子样本在培养后精子形态和活力有显著改善。培养的睾丸精子活力在72小时达到峰值,无需特殊培养基。从非梗阻性无精子症患者获取的20个样本中有6个观察到精子活力改善。仅培养无活力的睾丸精子时,它们均仍无活力(n = 9)。在梗阻性无精子症患者中,使用新鲜及冻融睾丸精子进行ICSI的受精率分别为80%和81%。使用新鲜睾丸精子的9名患者中有4名观察到临床妊娠,使用冻融精子的5名患者中有2名观察到临床妊娠。当使用从非梗阻性无精子症患者获取的新鲜睾丸精子进行ICSI时,受精率为68%,7名患者中有2名实现临床妊娠。总之,梗阻性无精子症患者新鲜及冻融睾丸精子的形态和活力在体外培养后可显著改善。非梗阻性无精子症患者睾丸精子的体外培养结果不可预测。迄今为止,无活力睾丸精子的体外培养未成功。使用新鲜及冻融睾丸精子进行ICSI的结果相似。